Evidence map›Paper›PMID 37840668›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Jie Xu, Zhenghao Zhang, Xiaofeng Ren, Yunan Zhang, Yang Zhou, Xiaorong Lan, Ling Guo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jie XuDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Zhenghao ZhangDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Xiaofeng RenDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Yunan ZhangDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Yang ZhouDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Xiaorong LanInstitute of Stomatology, Southwest Medical University, Luzhou, China.
Ling GuoDepartment of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral mucosal wounds exhibit an increased susceptibility to inflammation as a consequence of their direct exposure to a diverse range of microorganisms. This causes pain, slow healing, and other complications that interfere with patients' daily activities like eating and speaking. Consequently, patients experience a significant decline in their overall quality of life. Therefore, the pursuit of novel treatment approaches is of great importance. In this study, ginsenoside Rg1, a natural active substance extracted from ginseng root, was chosen as a therapeutic agent. It was encapsulated in a screened photo-crosslinked hydrogel scaffold for the treatment of mucosal defects in the rat palate. The results demonstrated that Rg1-hydrogel possessed excellent physical and chemical properties, and that oral mucosa wounds treated with Rg1-hydrogel exhibited the greatest healing performance, as evidenced by more pronounced wound re-epithelialization, increased collagen deposition, and decreased inflammatory infiltration. Subsequent investigations in molecular biology confirmed that Rg1-hydrogel stimulated the secretion of repair-related factors and inhibited the secretion of inflammatory factors. This study demonstrated that the hydrogel containing ginsenoside Rg1 significantly promotes oral mucosal tissue healing

Indexed as

antiinflammationginsenoside Rg1hydrogeloral mucosa woundtissue repairvisible-light crosslinking

Identifiers

PMID37840668
PMCPMC10569426
OpenAlexW4387184475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.